Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04486911 |
|---|---|
| Brief Title: | Pyrotinib Maleate, CDK4/6 Inhibitor and Letrozole in Combination for Stage II-III TPBC: a Phase II Trial |
| First Submitted : | July 21, 2020 |
| First Submitted that Met QC Criteria : | July 24, 2020 |
| First Posted : | July 27, 2020 |
| Last Update Submitted that Met QC Criteria : | July 30, 2022 |
| Last Update Posted : | August 2, 2022 |